Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations , 2015 , we hereby inform that CRISIL Rating Limited ("CRISIL Ratings") has reaffirmed the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
CRISIL Ratings has reaffirmed its lowest possible credit rating of 'Crisil D' for both long-term and short-term bank loan facilities of GKB Ophthalmics Ltd, totalling Rs. 15.1 crore. The rating reflects the company's continued financial stress, including EBITDA losses for six straight years, a net loss of Rs. 3.62 crore in the first nine months of FY2025, and expected revenue of just Rs. 32 crore for FY2025. Liquidity is rated as poor, with bank limits fully utilised for the past twelve months and insufficient cash accruals to meet debt obligations. The only offsetting factor is the promoters' three-decade experience in the ophthalmic lens industry. An upgrade would require 90 days of timely debt servicing and a clear improvement in operating performance.
This is a deeply negative signal for shareholders — CRISIL D is the lowest rating on the scale and indicates the company is in or near default. Existing lenders face very high risk, and raising fresh capital or new loans will be extremely difficult. The stock is likely to remain under pressure, and investors should treat this as a high-risk, distressed situation.